SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)

SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS)

No trades
See on Supercharts

0QN1 fundamentals

SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) key financial stats and ratios

0QN1 price-to-sales ratio is 1.00. The company has an Enterprise Value to EBITDA ratio of 1.88. As of 2023 they employed 44 people.

Statistics
Price to earnings ratio
Price to cash flow ratio
Currency: CHF
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios